insulin efsitora (once weekly)
Jump to navigation
Jump to search
Indications
- treatment of diabetes mellitus type-2
Dosage
- once weekly infection
Adverse effects
Clinical trials
- QWINT-1 trial
- noninferior to once-daily glargine in reducing glycated hemoglobin levels.
More general terms
References
- ↑ Rosenstock J, Bailey T, Connery L et al; QWINT-1 trial investigators. Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. N Engl J Med. 2025 Jul 24;393(4):325-335. PMID: https://pubmed.ncbi.nlm.nih.gov/40548694 Clinical Trial. https://www.nejm.org/doi/10.1056/NEJMoa2502796